Helmut Brath
Vienna, 1020, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Plant-Based Nutrition and Type 2 Diabetes Mellitus: Prevention, Risk, Metabolic Health and the Role of Legumes, Dietary Fiber, and Red Meat.
Journal: Nutrients
Published: July 18, 2026
Austrian lipid consensus : Interdisciplinary evidence-based recommendations on prevention and treatment of lipid-associated diseases from 15 medical specialist societies
Journal: Wiener klinische Wochenschrift
Published: April 22, 2026
Antihyperglycemic treatment of type 2 diabetes mellitus (Update 2026)
Journal: Wiener klinische Wochenschrift
Published: January 02, 2026
Mini-review. Vitamin D for the prevention of type 2 diabetes: Evidence and implications.
Journal: Metabolism: clinical and experimental
Published: December 08, 2025
Smoking and nicotine use, heated tobacco products, psychological and socioeconomic aspects of dependence, alcohol, infections, vaccination and diabetes mellitus (Update 2026)
Journal: Wiener klinische Wochenschrift
Published: November 19, 2025
Excretion of glucose analogue with SGLT2 affinity predicts response effectiveness to sodium glucose transporter 2 inhibitors in patients with type 2 diabetes mellitus.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 06, 2023
Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2023)
Journal: Wiener klinische Wochenschrift
Published: March 01, 2023
Smoking, heated tobacco products, alcohol and diabetes mellitus (update 2023)
Journal: Wiener klinische Wochenschrift
Published: February 09, 2023
Other specific types of diabetes and exocrine pancreatic insufficiency (update 2023)
Journal: Wiener klinische Wochenschrift
Published: November 09, 2022
Lipid lowering therapy in primary and secondary prevention in Austria: are LDL-C goals achieved? : Results from the DA VINCI study.
Journal: Wiener klinische Wochenschrift
Published: July 05, 2021
Combined exenatide and dapagliflozin has no additive effects on reduction of hepatocellular lipids despite better glycaemic control in patients with type 2 diabetes mellitus treated with metformin: EXENDA, a 24-week, prospective, randomized, placebo-controlled pilot trial.
Journal: Diabetes, obesity & metabolism
Published: December 09, 2020
Sex-specific trends in smoking prevalence over seven years in different Austrian populations: results of a time-series cross-sectional analysis.
Journal: BMJ open
Published: September 10, 2020
Last Updated: 09/26/2026